Adverse events associated with albendazole and other products used for treatment of giardiasis in dogs

Journal of the American Veterinary Medical Association

Volumn 213, Issue 1, 1998, Pages 44-46

  Meyer, E Kathryn ^a  

^a UNITED STATES PHARMACOPEIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; ANTIPROTOZOAL AGENT; FENBENDAZOLE; MEPACRINE; METRONIDAZOLE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; CHEMICALLY INDUCED DISORDER; DOG; DOG DISEASE; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; GIARDIASIS; MEDICAL LITERATURE; UNITED STATES; ANIMAL TISSUE; BONE MARROW TOXICITY; DIARRHEA; DRUG APPROVAL; DRUG LABELING; DRUG POTENCY; DRUG SAFETY; NONHUMAN; ORAL DRUG ADMINISTRATION; REVIEW; TERATOGENESIS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ALBENDAZOLE; ANIMALS; ANTHELMINTICS; ANTIPROTOZOAL AGENTS; CAT DISEASES; CATS; DOG DISEASES; DOGS; FENBENDAZOLE; GIARDIASIS; METRONIDAZOLE; PHARMACOPOEIAS; QUINACRINE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0032113627     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Barr SC, Bowman DD, Heller RL. Efficacy of fenbendazole against giardiasis in dogs. Am J Vet Res 1994;55:988-990.
2. Zajac AM, LaBranche TP, Donoghue AR, et al. Efficacy of fenbendazole in the treatment of experimental Giardia infection in dogs. Am J Vet Res 1998;59:61-63.
3. Barr SC, Bowman DD, Heller RL, et al. Efficacy of albendazole against giardiasis in dogs. Am J Vet Res 1993;54:926-928.
4. Zimmer JF, Burrington DB. Comparison of four protocols for the treatment of canine giardiasis. J Am Anim Hosp Assoc 1986;22: 168-172.
5. Oral dosage forms of new animal drugs - fenbendazole granules. 21CFR520.905b. Code of Federal Regulations 1997.
6. Oral dosage forms of new animal drugs - albendazole. 21CFR520.45. Code of Federal Regulations 1997.
7. Stokol T, Randolph JF, Nachbar S, et al. Development of bone marrow toxicosis after albendazole administration in a dog and cat. J Am Vet Med Assoc 1997;210:1753-1756.
8. Dow SW, LeCouteur RA, Poss ML, et al. Central nervous system toxicosis associated with metronidazole treatment of dogs: five cases (1984-1987). J Am Vet Med Assoc 1989;195:365-368.
9. Davidson RR. Adverse reaction to quinacrine hydrochloride in a dog. VM SAC 1978;73:589-590.
10. Morgan UM, Reynoldson JA, Thompson RCA. Activities of several benzimidazoles and tubulin inhibitors against Giardia spp in vitro. Antimicrob Agents Chemother 1993;37:328-331.
11. Theodorides VJ, Daly IW, Kraeer P, et al. Human safety studies with albendazole, in Proceedings. Am Assoc Vet Parasitol 1989;41.
12. SmithKline Beecham Animal Health. Albendazole suspension for use in sheep. Freedom of information summary. NADA 140-934. West Chester, Pa: SmithKline Beecham Animal Health, 1994.
13. Zajac AM. Giardiasis. Compend Contin Educ Pract Vet 1992; 14:604-611.
14. USP DI drug information for the health care professional. Vol 1. Rockville, Md: United States Pharmacopeial Convention Inc, 1998;2469-2470.